Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Clinical trial NCT05803941 · RECRUITING

Trial details

NCT number: NCT05803941
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2023-08-14
Primary completion: 2033-07-20
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.